首页> 外文期刊>Health expectations: an international journal of public participation in health care and health policy >Patient choice and evidence based decisions: The case of complementary therapies.
【24h】

Patient choice and evidence based decisions: The case of complementary therapies.

机译:患者选择和循证决策:辅助疗法的情况。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: Current government policies simultaneously pursue the development of 'patient-led' and 'evidence-based' approaches to healthcare. The objective of this study was to explore how primary care clinicians and Primary Care Trust (PCT) managers balance these potentially competing tensions when considering popular, controversial treatments, like complementary therapies, in consultations (clinicians) or funding decisions (PCT managers). SETTING AND PARTICIPANTS: We selected two case sites where complementary therapies were offered on NHS premises in England. We interviewed 18 PCT managers and clinicians, conducted an observation of a PCT meeting on complementary therapies and collected documentary data from referral databases and service funding bids. All interviews were taped, transcribed and analysed thematically. Interview, observation and documentary data were used to compare reported beliefs and behaviour to observed and documented behaviour. RESULTS: The majority of clinicians and PCT managers claimed that research evidence guided their decisions; those who did not felt increasingly marginalized. However, discrepancies between reported and observed behaviour suggest that perceptions of research evidence, rather than fact based knowledge, predominated when considering complementary therapies. CONCLUSION: In the case of NHS complementary therapy service provision, patient preference may be largely insignificant in clinician and PCT managerial decisions, with decisions based mainly on 'evidence rhetoric' devised from collectively agreed, unchallenged, tacit perceptions of research literature. If a patient-led NHS is to become a reality, NHS professionals need to cede the power that they wield with evidence rhetoric and acknowledge the legitimacy of patient preferences, views and alternative sources of evidence.
机译:目的:当前的政府政策同时追求“病人主导”和“循证”医疗保健方法的发展。这项研究的目的是探讨在咨询(临床医生)或资助决策(PCT经理)中考虑流行的,有争议的治疗方法(如补充疗法)时,初级保健临床医生和初级保健信托(PCT)经理如何平衡这些潜在的竞争压力。地点和参与者:我们选择了两个案例地点,在英格兰的NHS场所提供了补充疗法。我们采访了18名PCT经理和临床医生,对PCT会议关于补充疗法的会议进行了观察,并从推荐数据库和服务资金招标中收集了文献数据。所有采访都进行录音,转录和主题分析。访谈,观察和文献数据被用来比较所报告的信仰和行为与观察和记录的行为。结果:大多数临床医生和PCT经理声称研究证据指导了他们的决定。那些没有感到越来越边缘化的人。但是,报告的行为与观察到的行为之间的差异表明,在考虑补充疗法时,对研究证据的认知而非基于事实的知识占主导。结论:就NHS辅助治疗服务的提供而言,在临床医生和PCT管理决策中,患者的偏好可能并不重要,其决策主要基于“证据修辞”,这些证据是根据研究文献的共同商定的,不受挑战的,默契的看法而设计的。如果要使以患者为主导的NHS成为现实,则NHS专业人员需要放弃他们在证据论证中所发挥的力量,并承认患者偏好,观点和替代证据来源的合法性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号